Assessment of Pre And Post Procedural Quality of Life In Successful Percutaneous Transvenous Mitral Commissurotomy Patient

Shahid  Mukarram; Muhammad   Shabbir; Huma  Mushtaq; Hira  Ahmad; Ayaz  Ahmad; Ahmed  Atta ul Haq; Muhammad   Essa

doi:10.51253/pafmj.v76iSUPPL-4.14173

Authors

Shahid Mukarram Department of Adult Cardiology, Armed Forces Institute of Cardiology/National Institute of Health Disease/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
Muhammad Shabbir Department of Adult Cardiology, Armed Forces Institute of Cardiology/National Institute of Health Disease/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
Huma Mushtaq Department of Adult Cardiology, Armed Forces Institute of Cardiology/National Institute of Health Disease/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
Hira Ahmad Department of Adult Cardiology, Armed Forces Institute of Cardiology/National Institute of Health Disease/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
Ayaz Ahmad Department of Adult Cardiology, Armed Forces Institute of Cardiology/National Institute of Health Disease/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
Ahmed Atta ul Haq Department of Adult Cardiology, Armed Forces Institute of Cardiology/National Institute of Health Disease/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
Muhammad Essa Department of Adult Cardiology, Armed Forces Institute of Cardiology/National Institute of Health Disease/National University of Medical Sciences (NUMS), Rawalpindi Pakistan

DOI:

https://doi.org/10.51253/pafmj.v76iSUPPL-4.14173

Keywords:

Mitral stenosis; Percutaneous Transvenous Mitral Commissurotomy; Quality of life; Rheumatic heart disease; WHOQOL-BREF

Abstract

Objective: To evaluate the effect of successful Percutaneous Transvenous Mitral Commissurotomy (PTMC) on clinical status and Quality of Life (QOL) in patients with severe rheumatic mitral stenosis applying the WHOQOL-BREF questionnaire.

Study Design: Analytical cross-sectional research.

Place and Duration of Study: Cardiology Department, Armed Forces Institute of Cardiology/National Institute of Heart Diseases (AFIC/NIHD), Rawalpindi, Oct-Dec 2025

Methodology: Thirty-five patients aged 15–65 years with symptomatic severe rheumatic mitral stenosis undergoing successful PTMC were enrolled using non-probability consecutive sampling. Patients with left atrial thrombus, Wilkins score >8, moderate–severe MR, significant AVD, or unsuccessful PTMC were excluded. The quality of life was checked one day before and again one month after PTMC using WHOQOL-BREF. The patient's clinical status was evaluated by the NYHA classification; p-value below 0.05 was considered significant.

Results: A total of 35 patients were included in the study. In patients under 40 years, the WHOQOL-BREF scores were 25.71 ± 1.93 for the physical domain, 22.0 (20.0–23.0) for the psychological domain, 12.0 (11.0–13.0) for the social domain, and 29.0 (28.0–35.0) for the environmental domain, with a total score of 88.0 (82.0–97.0). Quality of life improved significantly in all domains (p < 0.001), with total scores increased from 52.0 (48.0–57.0) to 86.0 (81.0–95.0) after the procedure

Conclusion: PTMC is a reliable and effective treatment option for patients with severe rheumatic mitral stenosis. The study shows that PTMC leads to clear improvement in mitral valve performance, functional capacity, and patients' perceived quality of life.

Downloads

Download data is not yet available.

References

1. Carapetis JR, Beaton A, Cunningham MW, Guilherme L, Karthikeyan G, Mayosi BM, et al. Acute rheumatic fever and rheumatic heart disease. Nat Rev Dis Primers. 2016; 2: 15084.

https://doi.org/10.1038/nrdp.2015.84

2. Muhamed B, Mutithu D, Aremu O, Zühlke L, Sliwa K. Rheumatic fever and rheumatic heart disease: Facts and research progress in Africa. Int J Cardiol. 2019; 295: 48-55.

https://doi.org/10.1016/j.ijcard.2019.07.084

3. Rizvi SF, Khan MA, Kundi A, Marsh DR, Samad A, Pasha O. Prevalence of rheumatic heart disease in school children of urban Lahore. Heart. 2004; 90(9): 1019-1020.

https://doi.org/10.1136/hrt.2003.025981

4. Stacey I, Hung J, Cannon J, Seth RJ, Remenyi B, Bond-Smith D, et al. Long-term outcomes following rheumatic heart disease diagnosis in Australia. Eur Heart J Open. 2021; 1(3): oeab035.

https://doi.org/10.1093/ehjopen/oeab035

5. Habib G, Lancellotti P, Antunes MJ. Management of rheumatic mitral stenosis: a contemporary review. Heart. 2022; 108(15): 1184-1192.

https://doi.org/10.1136/heartjnl-2021-320699

6. Cheung YB, Yeo KK, Chong KJ, Khoo EY, Wee HL. Reliability and validity of the English, Chinese and Malay versions of the World Health Organization quality of life (WHOQOL-BREF) questionnaire in Singapore. Ann Acad Med Singap. 2017; 46(12): 461-469.

https://doi.org/10.47102/annals-acadmedsg.V46N12p461

7. Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart disease. Lancet. 2012; 379(9819): 953-964. https://doi.org/10.1016/S0140-6736(11)61171-9

8. Bhardwaj P, Chaudhury S, Aneja A, Jetley V, Walia TS, Mujawar S. Assessment of quality of life before and after successful percutaneous transvenous mitral commissurotomy in patients with severe mitral stenosis. Ind Psychiatry J. 2019; 28(1): 51-57. https://doi.org/10.4103/ipj.ipj4-19

9. Watkins DA, Johnson CO, Colquhoun SM. Global, regional, and national burden of rheumatic heart disease, 1990-2021. Lancet Glob Health. 2023; 11(10): e1562-e1576.

https://doi: 10.1016/S2214-109X(23)00347-8

10. Rwebembera J, Bunting KV, Manji RA. World Heart Federation echocardiographic criteria and contemporary management of rheumatic heart disease. Nat Rev Cardiol. 2024; 21(2): 87-101. https://doi.org/10.1038/s41569-023-00935-6

11. Zühlke L, Beaton A, Engelman D . Valvular heart disease and patient-reported outcomes in low-resource settings. Circulation. 2021; 143(17): 1680-1690.

https://doi: 10.1161/CIRCULATIONAHA.120.050567

12. Vahanian A, Beyersdorf F, Praz F. ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022; (7): 561-632. https://doi.org/10.1093/eurheartj/ehab395

13. Iung B, Delgado V, Rosenhek R. Contemporary outcomes of percutaneous mitral commissurotomy. Eur Heart J. 2020; 41(26): 2596-2604. https://doi.org/10.1093/eurheartj/ehaa115

14. Elkaryoni A, Alkhouli M, Alqahtani F. In-hospital and readmission outcomes after percutaneous balloon mitral valvotomy. Am J Cardiol. 2022; 168: 72-78.

https://doi.org/10.1016/j.amjcard.2021.12.018

15. Munir S, Akbar MA, Alamgir A. Immediate clinical and echocardiographic outcomes of percutaneous transvenous mitral commissurotomy. J Cardiovasc Dis. 2021; 15(2): 45-50.

16. Adhikari CM, Malla R, Rajbhandari R. Percutaneous transvenous mitral commissurotomy in rheumatic mitral stenosis: clinical outcomes. Cardiovasc Diagn Ther. 2020; 10(2): 204-210.

https://doi.org/10.21037/cdt.2020.02.02

17. Ali L, Asghar N, Riaz R, Hussain M. Procedural success and early outcomes of PTMC in severe mitral stenosis. Prof Med J. 2021; 28(4): 556-561.

https://doi: 10.17957/TPMJ/21.4821

18. Sharma KH, Jain S, Shukla. Outcomes of percutaneous transvenous mitral commissurotomy in rheumatic mitral stenosis. Indian Heart J. 2020; 72(6): 495-500.

https://doi.org/10.1016/j.ihj.2020.09.003

19. Shabeer H. Study of clinical profile and in-hospital outcomes of patients undergoing percutaneous transvenous mitral commissurotomy. Biol Clin Sci Res J. 2025;6(5):148-151.

https://doi.org/10.54112/bcsrj.v6i5.1753

20. WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998; 28(3): 551-558.

https://doi.org/10.1017/S0033291798006667

21. Bauersachs J, Capodanno D, Conradi L, De Bonis M, De Paulis R, Delgado V et al ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European heart journal. 2023 Feb 14; 43(7): 561-632.https://doi.org/10.1093/ejcts/ezac209

22. Riaz A, Hanif MI, Khan IH, et al. Quality of life in patients with rheumatic heart disease: a cross-sectional study. J Pak Med Assoc. 2020; 70(3): 456-461